TADIM GIDA MADDELERI SANAYI VE TIC. A.S.
⚠️ Moderate Risk
FEI: 3004261545 • Tuzla, Istanbul • TURKEY
FEI Number
3004261545
Location
Tuzla, Istanbul
Country
TURKEYAddress
Istasyon Mah., E-5 Karayolu Tuzla, Tuzla, Istanbul, Turkey
Moderate Risk
FDA Import Risk Assessment
This firm has a moderate history of FDA import refusals. Some attention may be warranted.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
NUTRIT LBL
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be misbranded in that the label or labeling fails to bear the required nutrition information.
USUAL NAME
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(i)(1) of the FD&C Act in that the label fails to bear the common or usual name of the food, if any there be.
LABELING
The article appears in violation of FPLA because of its placement, form and/or contents statement.
LIST INGRE
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(i)(2) of the FD&C Act in that it is fabricated from two or more ingredients and the label fails to bear the common or usual name of each such ingredient and/or the article purports to be a beverage containing vegetable or fruit juice, but does not bear a statement with appropriate prominence on the information panel of the total percentage of such fruit or vegetable juice contained in the food.
LACKS FIRM
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(e)(1) of the FD&C Act in that the food is in package form and the label fails to bear the name and place of business of the manufacturer, packer, or distributor.
LACKS N/C
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(e)(2) of the FD&C Act in that the food is in package form and the label fails to bear an accurate statement of the quantity of the contents in terms of weight, measure, or numerical count in accordance with Section 403(e)(2) of the FD&C Act.
NO ENGLISH
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(f) of the FD&C Act in that any word, statement, or other information required by or under the authority of the FD&C Act to appear on the label or labeling is not prominently placed thereon with such conspicuousness (as compared with other words, statements, designs, or devices, in the labeling) and in such terms as to render it likely to be read and understood by the ordinary individual under customary terms of purchase and use (for example, label contains information in two or more languages but fails to repeat all required information in both languages in accordance with 21 CFR 101.15(c)(2), or label fails to include all required information in English in accordance with 21 CFR 101.15(c)(1), except in the case of articles distributed solely in the Commonwealth of Puerto Rico or in a Territory where the predominant language is one other than English)).
ALLERGEN
the label fails to declare all major food allergens present in the product, as required by section 403(w)(1).
AFLATOXIN
The article appears to contain a mycotoxin, a poisonous and deleterious substance which may render it injurious to health.
PB-FOOD
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to contain a poisonous or deleterious substance, lead, which may render it injurious to health.
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 4/11/2012 | 23BET07PEANUT, SHELLED | 297AFLATOXIN | New York District Office (NYK-DO) |
| 4/11/2012 | 23BET07PEANUT, SHELLED | 297AFLATOXIN | New York District Office (NYK-DO) |
| 6/6/2011 | 23BET07PEANUT, SHELLED | New York District Office (NYK-DO) | |
| 6/6/2011 | 23BET01ALMOND, SHELLED | New York District Office (NYK-DO) | |
| 6/6/2011 | 23BET07PEANUT, SHELLED | New York District Office (NYK-DO) | |
| 6/6/2011 | 23AET99NUTS, IN SHELL, N.E.C. | New York District Office (NYK-DO) | |
| 6/6/2011 | 24AET99BEANS, CORN, AND PEA, N.E.C. (VEGETABLE) | New York District Office (NYK-DO) | |
| 5/26/2009 | 20SGT99CORE FRUIT JUICES OR CONCENTRATES, N.E.C. | 3400PB-FOOD | New York District Office (NYK-DO) |
Frequently Asked Questions
What is TADIM GIDA MADDELERI SANAYI VE TIC. A.S.'s FDA import refusal history?
TADIM GIDA MADDELERI SANAYI VE TIC. A.S. (FEI: 3004261545) has 8 FDA import refusal record(s) in our database, spanning from 5/26/2009 to 4/11/2012.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. TADIM GIDA MADDELERI SANAYI VE TIC. A.S.'s FEI number is 3004261545.
What types of violations has TADIM GIDA MADDELERI SANAYI VE TIC. A.S. received?
TADIM GIDA MADDELERI SANAYI VE TIC. A.S. has been cited for 10 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about TADIM GIDA MADDELERI SANAYI VE TIC. A.S. come from?
All FDA import refusal data for TADIM GIDA MADDELERI SANAYI VE TIC. A.S. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.